文献速递慢性肾脏病血液净化与透析

糖尿病中肾衰竭与死亡风险的現實世界队列研究

A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes.
PubMed 文献 · Clin J Am Soc Nephrol · 2025-09-08

该研究基于Providence和加州大学洛杉矶分校健康系统的电子健康记录,纳入618,739例糖尿病患者,中位随访3.79年。结果显示,eGFR≥45 ml/min per 1.73 m2时死亡风险高于肾衰竭,而eGFR<30 ml/min per 1.73 m2时肾衰竭风险超过死亡。

要点

  • 在大型糖尿病人群中,总体死亡风险超过肾衰竭风险,但eGFR<30 ml/min per 1.73 m2时肾衰竭风险更高。
  • eGFR≥90 ml/min per 1.73 m2者5年肾衰竭累积发生率为2%,eGFR 15–29 ml/min per 1.73 m2者为62%。
  • 当前风险估计有助于支持公共卫生和临床策略,以监测和改善糖尿病患者的肾脏健康。

核心结论

  • 在eGFR≥45 ml/min per 1.73 m2时死亡可能性高于肾衰竭,但eGFR<30 ml/min per 1.73 m2时这一趋势反转。
  • 这些当代风险估计对于监测和干预以改善糖尿病肾脏健康的公共卫生和临床策略具有重要意义。

研究设计与样本

  • 基于Providence和加州大学洛杉矶分校健康系统电子健康记录数据的真实世界队列研究。
  • 纳入618,739例糖尿病患者,随访时间为2013–2022年,中位(四分位距)随访3.79(1.80–6.00)年。
  • 按基线eGFR分层估计肾衰竭和死亡的累积发生率函数,并使用Cox比例风险模型评估预测因素;肾衰竭分析中死亡作为竞争风险。

主要发现

  • 4%(n=24,097)发生肾衰竭,10%(n=63,128)死亡。
  • 5年肾衰竭累积发生率从eGFR≥90 ml/min per 1.73 m2的2%(95% CI 1.4%–1.5%)升至eGFR 15–29 ml/min per 1.73 m2的62%(95% CI 61.0%–63.5%)。
  • eGFR≥45 ml/min per 1.73 m2时全因死亡累积发生率高于肾衰竭,而eGFR<30 ml/min per 1.73 m2时肾衰竭更常见。
  • 肾衰竭风险在男性(参照:女性)、40–59岁和60–79岁组(参照:18–39岁)、非白人种族或西班牙裔/拉丁裔族群(参照:非西班牙裔白人)、非商业保险(参照:商业保险)或随访前1年内住院(是/否)者中更高。
  • 死亡风险相似,但≥80岁风险最高,且仅美洲印第安人或阿拉斯加原住民及其他种族组风险更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Rates and risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. In a large population with diabetes, risk of death exceeded kidney failure overall, but kidney failure outpaced death at eGFR <30 ml/min per 1.73 m2. Current risk estimates are needed to support public health and clinical strategies to monitor and improve kidney health in diabetes. BACKGROUND: Risks of kidney failure versus death in diabetes have not been previously quantified across a full range of kidney function. The aim of the study was to assess competing risks of kidney failure and death in a real-world cohort with diabetes. METHODS: Cumulative incidence (CMI) functions for kidney failure and death, stratified by baseline eGFR, were estimated for the diabetes population from electronic health record data at Providence and the University of California Los Angeles health systems. Cox proportional hazards models assessed predictors of kidney failure and death. For kidney failure, cause-specific hazards were modeled with competing risk of death. RESULTS: Among 618,739 persons with diabetes followed for a median (interquartile range) of 3.79 (1.80–6.00) years during 2013–2022, 4% (n=24,097) developed kidney failure and 10% (n=63,128) died. Five-year CMI of kidney failure increased from 2% (95% confidence interval, 1.4% to 1.5%) for eGFR ≥90 ml/min per 1.73 m2 to 62% (95% confidence interval, 61.0% to 63.5%) for eGFR 15–29 ml/min per 1.73 m2. CMI of all-cause death was higher than kidney failure with eGFR ≥45 ml/min per 1.73 m2, whereas kidney failure became more common at eGFR <30 ml/min per 1.73 m2. Hazards of kidney failure were higher in men (reference: women), 40–59 and 60–79-year groups (reference: 18–39 years), non-White race or Hispanic or Latino/a ethnicity groups (reference: non-Hispanic White), and by noncommercial (reference: commercial) health insurance or hospitalization (yes/no) within 1 year before follow-up. Hazards of death were similar except that age ≥80 years imparted the highest risk, and only the American Indian or Alaska Native and other race groups had higher risk. CONCLUSIONS: Death was more likely than kidney failure at eGFR ≥45 ml/min per 1.73 m2, but this trend reversed at eGFR <30 ml/min per 1.73 m2. These contemporary risk estimates are important for public health and clinical strategies for monitoring and interventions to improve kidney health in diabetes.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Tuttle KR, Kornowske LM, Jones CR, et al. A Real-World Cohort Study of the Risks of Kidney Failure and Death in Diabetes. Clin J Am Soc Nephrol. 2025. PMID: 40921151. doi:10.2215/CJN.0000000857

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。